The Clinical Diagnostics program offers clients unique insights into the competitive dynamics of the market, including coverage of sectors, such as molecular diagnostics, point-of-care testing, and in vitro diagnostics, from a regional and global perspective. Based on both quantitative and qualitative information, clients can leverage this information to stay abreast of challenges and trends, and to remain competitive and grow their businesses.
| Title | Published |
|---|---|
| North America; New Product Innovation Award - Colonoscope Visualization Solutions | 27 Mar 2017 |
|
APAC Molecular Diagnostics Market, Forecast to 2021
Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth |
23 Mar 2017 |
| Product Leadership Award - Elastography in Liver Disease Assessment | 17 Mar 2017 |
|
Game-changing Strategies of Leading US Pharma Companies
Focus on Beyond the Pill Services, Process Automation, and Patient Engagement across the Value Chain to Drive Growth |
14 Mar 2017 |
| Europe; Product Leadership Award - Next-Generation Sequencing Industry | 24 Feb 2017 |
| Global; Product Leadership Award - Clinical Media Workflow Solutions | 06 Feb 2017 |
|
European Next-generation Sequencing Services Market, Forecast to 2023
Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth |
02 Feb 2017 |
|
Global Precision Medicine Growth Opportunities, Forecast to 2025
Strategies and Tactics for Accelerating Growth in a Transforming Market |
18 Jan 2017 |
|
Game-changing Strategies of European Pharma Companies
Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory |
17 Jan 2017 |
|
2016 Global Survey on Clinical Next-Generation Sequencing
Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications |
09 Jan 2017 |
About this service
Help Desk
For more information and general enquiries, contact Frost & Sullivan near you.
Select a location near you..